Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - VANGUARD HEALTH SYSTEMS INC | c21865exv99w1.htm |
| EX-99.3 - EXHIBIT 99.3 - VANGUARD HEALTH SYSTEMS INC | c21865exv99w3.htm |
| 8-K - FORM 8-K - VANGUARD HEALTH SYSTEMS INC | c21865e8vk.htm |
EXHIBIT 99.2
Vanguard Health Systems, Inc.
Supplementary Financial Information
Supplementary Financial Information
Adjusted EBITDA Margin
Presentation of Most Directly Comparable GAAP Financial Measure (Net Income/Loss Attributable to Vanguard
Health Systems, Inc. Stockholders Margin)
and Reconciliation of Adjusted EBITDA to Net Income/Loss Attributable to Vanguard Health Systems, Inc.
Stockholders Margin
| Quarter ended | Year ended | |||||||||||||||
| June 30, | June 30, | |||||||||||||||
| (in millions, unaudited) | 2010 | 2011 | 2010 | 2011 | ||||||||||||
Adjusted EBITDA |
$ | 82.9 | $ | 130.3 | $ | 326.6 | $ | 423.0 | ||||||||
Total revenues |
858.4 | 1,501.8 | 3,376.9 | 4,895.9 | ||||||||||||
Adjusted EBITDA Margin |
9.7 | % | 8.7 | % | 9.7 | % | 8.6 | % | ||||||||
Adjusted EBITDA |
$ | 82.9 | $ | 130.3 | $ | 326.6 | $ | 423.0 | ||||||||
Interest, net |
(30.8 | ) | (53.3 | ) | (115.5 | ) | (171.2 | ) | ||||||||
Income tax benefit (expense) |
(4.4 | ) | 2.4 | 13.8 | (9.3 | ) | ||||||||||
Depreciation and amortization |
(37.7 | ) | (62.2 | ) | (139.6 | ) | (193.8 | ) | ||||||||
Non-controlling interests |
(0.8 | ) | (1.0 | ) | (2.9 | ) | (3.6 | ) | ||||||||
Gain (loss) on disposal of assets |
(1.4 | ) | 1.1 | (1.8 | ) | 0.2 | ||||||||||
Equity method income |
0.1 | 0.3 | 0.9 | 0.9 | ||||||||||||
Stock compensation |
(0.7 | ) | (1.2 | ) | (4.2 | ) | (4.8 | ) | ||||||||
Monitoring fees and expenses |
(1.2 | ) | (27.6 | ) | (5.1 | ) | (31.3 | ) | ||||||||
Realized gains on investments |
— | 1.4 | — | 1.3 | ||||||||||||
Acquisition related expenses |
(3.1 | ) | (0.6 | ) | (3.1 | ) | (12.5 | ) | ||||||||
Debt extinguishment costs |
(0.3 | ) | — | (73.5 | ) | — | ||||||||||
Impairment and restructuring charges |
— | — | (43.1 | ) | (6.0 | ) | ||||||||||
Pension credits |
— | 1.0 | — | 2.1 | ||||||||||||
Income (loss) from discontinued
operations, net of taxes |
0.2 | (0.5 | ) | (1.7 | ) | (5.9 | ) | |||||||||
Net income (loss) attributable to Vanguard
Health Systems, Inc. stockholders |
$ | 2.8 | $ | (9.9 | ) | $ | (49.2 | ) | $ | (10.9 | ) | |||||
Total revenues |
$ | 858.4 | $ | 1,501.8 | $ | 3,376.9 | $ | 4,895.9 | ||||||||
Net income (loss) attributable to Vanguard
Health Systems, Inc. stockholders
margin |
0.3 | % | (0.7 | )% | (1.5 | )% | (0.2 | )% | ||||||||